CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 67 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 29.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $748,000 | -18.3% | 305,000 | 0.0% | 0.11% | -12.2% |
Q3 2015 | $915,000 | -83.1% | 305,000 | -76.7% | 0.12% | -80.5% |
Q2 2015 | $5,411,000 | +16.2% | 1,310,000 | +21.9% | 0.63% | +18.2% |
Q1 2015 | $4,655,000 | +64.1% | 1,075,000 | +12.6% | 0.53% | +60.4% |
Q4 2014 | $2,836,000 | -10.6% | 955,000 | 0.0% | 0.33% | -18.6% |
Q3 2014 | $3,171,000 | +51.0% | 955,000 | +15.1% | 0.41% | +19.2% |
Q2 2014 | $2,100,000 | – | 830,000 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |